Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling

Cancer Gene Therapy, Published online: 28 January 2020; doi:10.1038/s41417-020-0163-1Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling

Source: Cancer Gene Therapy - January 27, 2020 Category: Cancer & Oncology Authors: Minhai Dong Qungen Xiao Jinyang Hu Fangling Cheng Po Zhang Weifeng Zong Qiaoying Tang Xiaopeng Li Feng Mao Yue He Xingjiang Yu Feng Wan Ting Lei Dongsheng Guo Baofeng Wang Source Type: research